![Michael Solomon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Solomon
Director/Board Member at
PROTARA THERAPEUTICS, INC.
Net worth: 101 230 $ as of 2026-06-29
Profile
Michael E.
Solomon was the founder of Epizyme, Inc. (2007) and served as Vice President-Discovery.
Current jobs include Independent Director at Protara Therapeutics, Inc. (2018) and Director at ValenzaBio, Inc. (2021).
Former jobs include Chief Executive Officer & Director at Ribometrix, Inc. (2017-2025), Director at ArTara Subsidiary, Inc., Principal at Millennium Pharmaceuticals, Inc., Chief Business Officer at Link Medicine Corp.
(2009-2012), Senior Associate at Banc of America Securities LLC, Venture Capital at SV Health Investors LLC (2016-2018), Chief Operating Officer at Ember Therapeutics, Inc. (2012-2015), Chief Operating Officer at Decibel Therapeutics, Inc. (2015-2016), and Vice President-Discovery at Hypnion, Inc. (2003-2007).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-14 | 26,500 ( 0.05% ) | 101 230 $ | 2026-06-29 |
Michael Solomon active positions
| Companies | Position | Start |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 2019-12-31 |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Director/Board Member | 2021-05-31 |
Former positions of Michael Solomon
| Companies | Position | End |
|---|---|---|
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Chief Executive Officer | 2025-01-08 |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Corporate Officer/Principal | 2018-11-30 |
| DECIBEL THERAPEUTICS, INC. | Chief Operating Officer | 2015-12-31 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Chief Operating Officer | 2014-12-31 |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Corporate Officer/Principal | 2011-12-31 |
Training of Michael Solomon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Health Technology |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Michael Solomon
